IL2 and neoplasm: The expression of the IL-2 Rα subunit on CD4+ regulatory T cells (Tregs) results in the preferential stimulation of these immunosuppressive cell types and is reported to limit the stimulatory effects of IL-2 on effector populations needed for anti-tumor responses7,8.